On March 14 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of fourth quarter 2015 and non-audited financial results of 12 months 2015, as well as informed about the other recent activities within the company.

During the presentation Salvis Lapiņš noted that JSC Olainfarm intends to pay dividends for 2015 and next few years, however considering the recent and planned acquisitions the proposal from the management board of JSC Olainfarm currently is to freeze the payout ratio at 15% for next three years.

The recorded Olainfarm webinar is available online: ej.uz/OLF_YE2015_video, and the presentation, demonstrated during the webinar, is available here: Webinar Presentation: 4th quarter and the whole 2015

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv